| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sotera Health Co | CFO and Treasurer | Common Stock, $0.01 par value per share ("Common Stock") | 739K | $10.3M | $13.93 | Mar 2, 2022 | Direct |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | Chief Financial Officer | Class A Common Stock | 4.86M | $4.76M | $0.98 | Jan 25, 2024 | Direct |
| MYRIAD GENETICS INC | Chief Financial Officer | Common Stock | 165K | $3.62M | $21.98 | Mar 14, 2024 | Direct |
| Sotera Health Co | CFO and Treasurer | Stock Options | 95.8K | Mar 2, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | Mar 14, 2024 | 1 | $0 | 4/A | Mar 28, 2024 | Chief Financial Officer |
| MYGN | MYRIAD GENETICS INC | Mar 14, 2024 | 1 | $0 | 4 | Mar 18, 2024 | Chief Financial Officer |
| MYGN | MYRIAD GENETICS INC | Jan 29, 2024 | 1 | $0 | 4 | Jan 29, 2024 | Chief Financial Officer |
| MYGN | MYRIAD GENETICS INC | Jan 29, 2024 | 0 | $0 | 3 | Jan 29, 2024 | Chief Financial Officer |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jan 25, 2024 | 1 | -$81.9K | 4 | Jan 29, 2024 | Chief Financial Officer |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Oct 31, 2023 | 1 | $0 | 4 | Nov 2, 2023 | Chief Financial Officer |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Oct 25, 2023 | 1 | -$113K | 4 | Oct 27, 2023 | Chief Financial Officer |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jul 25, 2023 | 1 | -$422K | 4 | Jul 26, 2023 | Chief Financial Officer |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jul 25, 2022 | 1 | $0 | 4 | Jul 26, 2022 | Chief Financial Officer |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | Jul 25, 2022 | 0 | $0 | 3 | Jul 26, 2022 | Chief Financial Officer |
| SHC | Sotera Health Co | Mar 2, 2022 | 2 | $0 | 4 | Mar 4, 2022 | CFO and Treasurer |
| SHC | Sotera Health Co | Nov 20, 2021 | 1 | -$87.8K | 4 | Nov 23, 2021 | CFO and Treasurer |